Biomarin Pharmaceutical Inc at JPMorgan Healthcare Conference Transcript
Great. Good afternoon, and welcome back to the 48th Annual JPMorgan Healthcare Conference. My name is Cory Kasimov. I'm a Senior Large-cap Biotech Analyst, and it's my pleasure to introduce BioMarin, and Chairman and CEO, J.J. Bienaimeé. (Operator Instructions)
So with that, J.J., thanks, as always, for being here. Thanks as well for putting out some good data ahead of the conference. Let me turn things over to you for an update.
Okay. Thank you, Cory. And I'm on Slide 1 here because I cannot actually see the slides that are on the screen for you. So thank you for listening today. So I'm moving to Slide 2 of the presentation that has a safe harbor statements. I just wish to highlight that I and some of our other BioMarin's executives might be making some forward-looking statements during this Zoom call. So please refer to our filings with the SEC for more information.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
